医学
四分位间距
相对风险
肺癌
全肺切除术
回顾性队列研究
人口
队列
外科
癌症
队列研究
内科学
置信区间
环境卫生
作者
Dhruvin H. Hirpara,Natalie G. Coburn,Gail Elizabeth Darling,Biniam Kidane,Mathieu Rousseau,Vaibhav Gupta,Mark K. Doherty,Victoria Zuk,Victoria Delibasic,Wing C. Chan,Julie I. Hallet
出处
期刊:Annals of Surgery
[Lippincott Williams & Wilkins]
日期:2021-02-27
卷期号:277 (2): e428-e438
被引量:15
标识
DOI:10.1097/sla.0000000000004802
摘要
OBJECTIVE: To conduct a population-level analysis of temporal trends and risk factors for high symptom burden in patients receiving surgery for non-small cell lung cancer (NSCLC). BACKGROUND: A population-level overview of symptoms after curative intent surgery is necessary to inform decision making and supportive care for patients with lung cancer. METHODS: Retrospective cohort study of patients receiving surgery for stages I to III NSCLC between January 2007 and September 2018. Prospectively collection Edmonton Symptom Assessment System (ESAS) scores, linked to provincial administrative data, were used to describe the prevalence, trajectory, and predictors of moderate-to-severe symptoms in the year following surgery. RESULTS: A total of 5350 patients, with 28,490 unique ESAS assessments, were included in the analysis. Moderate-to-severe tiredness (68%), poor wellbeing (63%), and shortness of breath (60%) were the most common symptoms reported. The rise and fall in the proportion of patients experiencing moderate-to-severe symptoms after surgery coincided with the median time to first (58 days, interquartile range: 47-72) and last cycle of chemotherapy (140 days, interquartile range: 118-168), respectively. There was eventual stabilization, albeit above the preoperative baseline, within 6 to 7 months after surgery. Female sex (relative risk [RR] 1.09- 1.26), lower income (RR 1.08-1.23), stage III disease (RR 1.15-1.43), adjuvant therapy (RR 1.09-1.42), chemotherapy within 2 weeks of an ESAS assessment (RR 1.14-1.73), and pneumonectomy (RR 1.05-1.15) were associated with moderate-to-severe symptoms following surgery. CONCLUSIONS: Knowledge of population-level prevalence, trajectory, and predictors of moderate-to-severe symptoms after surgery for NSCLC can be used to facilitate shared decision making and improve symptom management throughout the course of illness.
科研通智能强力驱动
Strongly Powered by AbleSci AI